DRIZALMA SPRINKLE

SUN PHARMACEUTICAL INDUSTRIES, INC.🇺🇸 United States

FDA Page

Effective Date: Jul 28, 2021
Approval ID: b41423b8-dfec-4d79-ba3c-e43a87803d85
Products: 4 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DRIZALMA SPRINKLE safely and effectively. See full prescribing information for DRIZALMA SPRINKLE. DRIZALMA SPRINKLE™ (duloxetine delayed-release capsules), for oral use. Initial U.S. Approval: 2004

Quick Stats

Total Products4

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.